🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessInternational health insurance and GLP-1 — anyone have experience? Page 4

International health insurance and GLP-1 — anyone have experience?

SaraMom3 Mon, Feb 2, 2026 at 9:30 AM 33 replies 1,641 viewsPage 4 of 7
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Feb 7, 2026 at 1:10 PM#16

Adding the clinical framing, because it changes how the question reads. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

50 23CryptoCarl, MariaRD, AussieAnna and 47 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Feb 7, 2026 at 8:12 PM#17
anders_CPH said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

This matches mine closely enough to be worth saying so out loud.

1 24InsuranceTom
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Feb 8, 2026 at 3:14 AM#18
anders_CPH said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

There is a second half to this that has not been said yet. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

2 0BiostatsBrad, PeptideSynthNJ
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Feb 8, 2026 at 10:16 AM#19

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

I would rather be corrected than agreed with, if it comes to it.

3 1MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 8, 2026 at 5:17 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Carry on.

25 23PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 22 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register